Persistent URL of this record https://hdl.handle.net/1887/115740
In Collections
This item can be found in the following collections:
![Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD (TM) study](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD (TM) study
- All authors
- Pollack, C.V.; Bernstein, R.; Dubiel, R.; Reilly, P.; Gruenenfelder, F.; Huisman, M.V.; Kam, C.W.; Kleine, E.; Levy, J.H.; Sellke, F.W.; Steiner, T.; Ustyugova, A.; Weitz, J.I.
- Date
- 2017-05-31
- Volume
- 20
- Issue
- 5
- Pages
- 435 - 442